A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer.
De Placido S, De Laurentiis M, De Lena M, Lorusso V, Paradiso A, D'Aprile M, Pistillucci G, Farris A, Sarobba MG, Palazzo S, Manzione L, Adamo V, Palmeri S, Ferraù F, Lauria R, Pagliarulo C, Petrella G, Limite G, Costanzo R, Bianco AR; GOCSI Cooperative Group.
De Placido S, et al. Among authors: pagliarulo c.
Br J Cancer. 2005 Feb 14;92(3):467-74. doi: 10.1038/sj.bjc.6602355.
Br J Cancer. 2005.
PMID: 15668708
Free PMC article.
Clinical Trial.